Daniil Gataulin
Stock Analyst at Chardan Capital
(4.82)
# 114
Out of 5,081 analysts
120
Total ratings
65.49%
Success rate
37.63%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Daniil Gataulin
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RGNX REGENXBIO | Maintains: Buy | $52 | $12.88 | +303.73% | 14 | Nov 20, 2025 | |
| FBRX Forte Biosciences | Maintains: Buy | $61 | $18.13 | +236.46% | 7 | Nov 17, 2025 | |
| KOD Kodiak Sciences | Maintains: Neutral | $14 | $22.96 | -39.02% | 4 | Nov 17, 2025 | |
| ZURA Zura Bio | Maintains: Buy | $10 | $3.68 | +171.74% | 3 | Nov 14, 2025 | |
| MGTX MeiraGTx Holdings | Maintains: Buy | $35 | $8.12 | +331.03% | 7 | Nov 14, 2025 | |
| IRD Opus Genetics | Maintains: Buy | $9 | $2.09 | +330.62% | 3 | Nov 13, 2025 | |
| QURE uniQure | Maintains: Buy | $53 | $25.48 | +108.01% | 10 | Nov 11, 2025 | |
| OCS Oculis Holding AG | Maintains: Buy | $51 | $19.02 | +168.14% | 9 | Nov 11, 2025 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $21 | $11.46 | +83.25% | 3 | Nov 5, 2025 | |
| OCGN Ocugen | Maintains: Buy | $7 | $1.21 | +478.51% | 14 | Sep 19, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $3 | $1.97 | +52.28% | 10 | Aug 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $33 | $4.17 | +691.37% | 8 | Aug 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $15 | $8.28 | +81.16% | 7 | Aug 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $4 | $1.80 | +122.22% | 8 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $27 | $14.52 | +85.95% | 12 | Aug 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $220 | $0.78 | +27,936.19% | 1 | Mar 7, 2024 |
REGENXBIO
Nov 20, 2025
Maintains: Buy
Price Target: $52
Current: $12.88
Upside: +303.73%
Forte Biosciences
Nov 17, 2025
Maintains: Buy
Price Target: $61
Current: $18.13
Upside: +236.46%
Kodiak Sciences
Nov 17, 2025
Maintains: Neutral
Price Target: $14
Current: $22.96
Upside: -39.02%
Zura Bio
Nov 14, 2025
Maintains: Buy
Price Target: $10
Current: $3.68
Upside: +171.74%
MeiraGTx Holdings
Nov 14, 2025
Maintains: Buy
Price Target: $35
Current: $8.12
Upside: +331.03%
Opus Genetics
Nov 13, 2025
Maintains: Buy
Price Target: $9
Current: $2.09
Upside: +330.62%
uniQure
Nov 11, 2025
Maintains: Buy
Price Target: $53
Current: $25.48
Upside: +108.01%
Oculis Holding AG
Nov 11, 2025
Maintains: Buy
Price Target: $51
Current: $19.02
Upside: +168.14%
Ocular Therapeutix
Nov 5, 2025
Maintains: Buy
Price Target: $21
Current: $11.46
Upside: +83.25%
Ocugen
Sep 19, 2025
Maintains: Buy
Price Target: $7
Current: $1.21
Upside: +478.51%
Aug 28, 2025
Maintains: Neutral
Price Target: $3
Current: $1.97
Upside: +52.28%
Aug 13, 2025
Maintains: Buy
Price Target: $33
Current: $4.17
Upside: +691.37%
Aug 11, 2025
Maintains: Buy
Price Target: $15
Current: $8.28
Upside: +81.16%
Aug 8, 2025
Maintains: Buy
Price Target: $4
Current: $1.80
Upside: +122.22%
Aug 7, 2025
Maintains: Buy
Price Target: $27
Current: $14.52
Upside: +85.95%
Mar 7, 2024
Maintains: Buy
Price Target: $220
Current: $0.78
Upside: +27,936.19%